Literature DB >> 25108559

Mutation frequency of PRKAR1B and the major familial dementia genes in a Dutch early onset dementia cohort.

P E Cohn-Hokke1, T H Wong, P Rizzu, G Breedveld, W M van der Flier, P Scheltens, F Baas, P Heutink, E J Meijers-Heijboer, J C van Swieten, Y A L Pijnenburg.   

Abstract

Genetic factors are important in all forms of dementia, especially in early onset dementia. The frequency of major gene defects in dementia has not been investigated in the Netherlands. Furthermore, whether the recently in a FTD family identified PRKAR1B gene is associated with an Alzheimer's disease (AD) like phenotype, has not been studied. With this study, we aimed to investigate the mutation frequency of the major AD and FTD genes and the PRKAR1B gene in a well-defined Dutch cohort of patients with early onset dementia. Mutation analysis of the genes PSEN1, APP, MAPT, GRN, C9orf72 and PRKAR1B was performed on DNA of 229 patients with the clinical diagnosis AD and 74 patients with the clinical diagnosis FTD below the age of 70 years. PSEN1 and APP mutations were found in, respectively 3.5 and 0.4 % of AD patients, and none in FTD patients. C9orf72 repeat expansions were present in 0.4 % of AD and in 9.9 % of FTD patients, whereas MAPT and GRN mutations both were present in 0.4 % in AD patients, and in 1.4 % resp. 2.7 % in FTD patients. We did not find any pathogenic mutations in the PRKAR1B gene. PSEN1 mutations are the most common genetic cause in Dutch AD patients, whereas MAPT and GRN mutations were found in less than 5 percent. C9orf72 repeat expansions were the most common genetic defect in FTD patients. No pathogenic PRKAR1B mutations were found in the early onset AD and FTD patients of our study.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25108559     DOI: 10.1007/s00415-014-7456-y

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  23 in total

1.  The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data.

Authors:  Aaron McKenna; Matthew Hanna; Eric Banks; Andrey Sivachenko; Kristian Cibulskis; Andrew Kernytsky; Kiran Garimella; David Altshuler; Stacey Gabriel; Mark Daly; Mark A DePristo
Journal:  Genome Res       Date:  2010-07-19       Impact factor: 9.043

2.  The R269H mutation in presenilin-1 presenting as late-onset autosomal dominant Alzheimer's disease.

Authors:  A J Larner; P S Ray; M Doran
Journal:  J Neurol Sci       Date:  2006-12-26       Impact factor: 3.181

Review 3.  Current state and future directions of neurochemical biomarkers for Alzheimer's disease.

Authors:  Daniëlle de Jong; Berry P H Kremer; Marcel G M Olde Rikkert; Marcel M Verbeek
Journal:  Clin Chem Lab Med       Date:  2007       Impact factor: 3.694

4.  The Sequence Alignment/Map format and SAMtools.

Authors:  Heng Li; Bob Handsaker; Alec Wysoker; Tim Fennell; Jue Ruan; Nils Homer; Gabor Marth; Goncalo Abecasis; Richard Durbin
Journal:  Bioinformatics       Date:  2009-06-08       Impact factor: 6.937

5.  Familial Alzheimer's disease genes in Japanese.

Authors:  K Kamimura; H Tanahashi; H Yamanaka; K Takahashi; T Asada; T Tabira
Journal:  J Neurol Sci       Date:  1998-09-18       Impact factor: 3.181

6.  PRKAR1B mutation associated with a new neurodegenerative disorder with unique pathology.

Authors:  Tsz Hang Wong; Wang Zheng Chiu; Guido J Breedveld; Ka Wan Li; Annemieke J M H Verkerk; David Hondius; Renate K Hukema; Harro Seelaar; Petra Frick; Lies-Anne Severijnen; Gert-Jan Lammers; Joyce H G Lebbink; Sjoerd G van Duinen; Wouter Kamphorst; Annemieke J Rozemuller; E Bert Bakker; Manuela Neumann; Rob Willemsen; Vincenzo Bonifati; August B Smit; John van Swieten
Journal:  Brain       Date:  2014-04-09       Impact factor: 13.501

Review 7.  Mutations in progranulin (GRN) within the spectrum of clinical and pathological phenotypes of frontotemporal dementia.

Authors:  John C van Swieten; Peter Heutink
Journal:  Lancet Neurol       Date:  2008-09-02       Impact factor: 44.182

8.  The C9ORF72 expansion mutation is a common cause of ALS+/-FTD in Europe and has a single founder.

Authors:  Bradley N Smith; Stephen Newhouse; Aleksey Shatunov; Caroline Vance; Simon Topp; Lauren Johnson; Jack Miller; Younbok Lee; Claire Troakes; Kirsten M Scott; Ashley Jones; Ian Gray; Jamie Wright; Tibor Hortobágyi; Safa Al-Sarraj; Boris Rogelj; John Powell; Michelle Lupton; Simon Lovestone; Peter C Sapp; Markus Weber; Peter J Nestor; Helenius J Schelhaas; Anneloor Alm Ten Asbroek; Vincenzo Silani; Cinzia Gellera; Franco Taroni; Nicola Ticozzi; Leonard Van den Berg; Jan Veldink; Phillip Van Damme; Wim Robberecht; Pamela J Shaw; Janine Kirby; Hardev Pall; Karen E Morrison; Alex Morris; Jacqueline de Belleroche; J M B Vianney de Jong; Frank Baas; Peter M Andersen; John Landers; Robert H Brown; Michael E Weale; Ammar Al-Chalabi; Christopher E Shaw
Journal:  Eur J Hum Genet       Date:  2012-06-13       Impact factor: 4.246

9.  Early onset familial Alzheimer's disease: Mutation frequency in 31 families.

Authors:  J C Janssen; J A Beck; T A Campbell; A Dickinson; N C Fox; R J Harvey; H Houlden; M N Rossor; J Collinge
Journal:  Neurology       Date:  2003-01-28       Impact factor: 9.910

10.  A blinded international study on the reliability of genetic testing for GGGGCC-repeat expansions in C9orf72 reveals marked differences in results among 14 laboratories.

Authors:  Chizuru Akimoto; Alexander E Volk; Marka van Blitterswijk; Marleen Van den Broeck; Claire S Leblond; Serge Lumbroso; William Camu; Birgit Neitzel; Osamu Onodera; Wouter van Rheenen; Susana Pinto; Markus Weber; Bradley Smith; Melanie Proven; Kevin Talbot; Pamela Keagle; Alessandra Chesi; Antonia Ratti; Julie van der Zee; Helena Alstermark; Anna Birve; Daniela Calini; Angelica Nordin; Daniela C Tradowsky; Walter Just; Hussein Daoud; Sabrina Angerbauer; Mariely DeJesus-Hernandez; Takuya Konno; Anjali Lloyd-Jani; Mamede de Carvalho; Kevin Mouzat; John E Landers; Jan H Veldink; Vincenzo Silani; Aaron D Gitler; Christopher E Shaw; Guy A Rouleau; Leonard H van den Berg; Christine Van Broeckhoven; Rosa Rademakers; Peter M Andersen; Christian Kubisch
Journal:  J Med Genet       Date:  2014-04-04       Impact factor: 6.318

View more
  3 in total

1.  Reply: PRKAR1B mutations are a rare cause of FUS negative neuronal intermediate filament inclusion disease.

Authors:  Tsz Hang Wong; Annemieke J M H Verkerk; Annemieke J Rozemuller; Rob Willemsen; Manuela Neumann; Vincenzo Bonifati; John van Swieten
Journal:  Brain       Date:  2014-11-19       Impact factor: 13.501

Review 2.  Tau and MAPT genetics in tauopathies and synucleinopathies.

Authors:  Etienne Leveille; Owen A Ross; Ziv Gan-Or
Journal:  Parkinsonism Relat Disord       Date:  2021-09-14       Impact factor: 4.402

3.  Lysosomal dysfunction in the brain of a mouse model with intraneuronal accumulation of carboxyl terminal fragments of the amyloid precursor protein.

Authors:  G Kaur; M Pawlik; S E Gandy; M E Ehrlich; J F Smiley; E Levy
Journal:  Mol Psychiatry       Date:  2016-10-25       Impact factor: 15.992

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.